Aims Loop diuretics have become a mainstay of chronic heart failure management.
Furosemide and torsemide are the two most common loop diuretics; nevertheless, there is …

Although torsemide's oral bioavailability and half-life theoretically render it a more efficient
diuretic than furosemide, the clinical outcomes of torsemide compared with furosemide …

Aim: The authors assessed the comparative effectiveness of torsemide versus furosemide in
the PROTECT trial. Methods: The authors assessed the relationship between loop diuretic at …

Objectives To compare the efficacy and safety of torsemide versus furosemide in patients
with heart failure (HF). Data sources Medline, Cochrane Library, Web of Science, and …

Background and objective Despite potential advantages of torsemide over furosemide,<
10% of the patients with heart failure (HF) are on torsemide in clinical practice. Prior studies …

Furosemide is the most widely prescribed loop diuretic in the setting of systolic heart failure
(HF), yet torsemide has been shown to have less inter-and intra-individual variation in …

In 2012, total cost for heart failure (HF) was $30.7 billion and by 2030, it is projected to
increase to $69.7 billion [1]. Hospitalizations for HF are a major reason for increased cost …

Furosemide has historically been the primary loop diuretic in heart failure patients despite
data suggesting potential advantages with torsemide. We used the Duke Echocardiography …

Importance Differences in clinical profiles, outcomes, and diuretic treatment effects may exist
between patients with de novo heart failure (HF) and worsening chronic HF (WHF) …

Purpose Current clinical recommendations do not emphasise superiority of any of diuretics,
but available reports are very encouraging and suggest beneficial effects of torasemide. This …